Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Davis, JRE; Farrell, WE; Clayton, RN
   Pituitary tumours
   REPRODUCTION
   
   J.R.E. Davis et al., "Pituitary tumours", REPRODUCT, 121(3), 2001, pp. 363-371
2. Clayton, RN; Farrell, WE
   Clonality of pituitary tumours: More complicated than initially envisaged?
   BRAIN PATHOLOGY
   
   R.N. Clayton e W.E. Farrell, "Clonality of pituitary tumours: More complicated than initially envisaged?", BRAIN PATH, 11(3), 2001, pp. 313-327
3. Frost, SJ; Simpson, DJ; Farrell, WE
   Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta 1-induced expression of p15/INK4B
   MOLECULAR AND CELLULAR ENDOCRINOLOGY
   
   S.J. Frost et al., "Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta 1-induced expression of p15/INK4B", MOL C ENDOC, 176(1-2), 2001, pp. 29-37
4. Zahedi, A; Booth, GL; Smyth, HS; Farrell, WE; Clayton, RN; Asa, SL; Ezzat, S
   Distinct clonal composition of primary and metastatic adrencorticotrophic hormone-producing pituitary carcinoma
   CLINICAL ENDOCRINOLOGY
   
   A. Zahedi et al., "Distinct clonal composition of primary and metastatic adrencorticotrophic hormone-producing pituitary carcinoma", CLIN ENDOCR, 55(4), 2001, pp. 549-556
5. Simpson, DJ; Frost, SJ; Bicknell, JE; Broome, JC; McNicol, AM; Clayton, RN; Farrell, WE
   Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas
   CARCINOGENESIS
   
   D.J. Simpson et al., "Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas", CARCINOGENE, 22(8), 2001, pp. 1149-1154
6. Simpson, DJ; Fryer, AA; Grossman, AB; Wass, JAH; Pfeifer, M; Kros, JM; Clayton, RN; Farrell, WE
   Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas
   CARCINOGENESIS
   
   D.J. Simpson et al., "Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas", CARCINOGENE, 22(11), 2001, pp. 1801-1807
7. Clayton, RN; Pfeifer, M; Atkinson, AB; Belchetz, P; Wass, JAH; Kyrodimou, E; Vanderpump, M; Simpson, D; Bicknell, J; Farrell, WE
   Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins
   CLINICAL CANCER RESEARCH
   
   R.N. Clayton et al., "Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins", CLIN CANC R, 6(10), 2000, pp. 3973-3982
8. Farrell, WE; Clayton, RN
   Molecular pathogenesis of pituitary tumors
   FRONTIERS IN NEUROENDOCRINOLOGY
   
   W.E. Farrell e R.N. Clayton, "Molecular pathogenesis of pituitary tumors", FRONT NEURO, 21(3), 2000, pp. 174-198
9. Simpson, DJ; Hibberts, NA; McNicol, AM; Clayton, RN; Farrell, WE
   Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island
   CANCER RESEARCH
   
   D.J. Simpson et al., "Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island", CANCER RES, 60(5), 2000, pp. 1211-1216
10. Farrell, WE; Clayton, RN
    Tumour suppressor genes in pituitary tumour formation
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    
    W.E. Farrell e R.N. Clayton, "Tumour suppressor genes in pituitary tumour formation", BEST PRAC R, 13(3), 1999, pp. 381-393
11. Farrell, WE; Simpson, DJ; Frost, SJ; Clayton, RN
    Methylation mechanisms in pituitary tumorigenesis
    ENDOCRINE-RELATED CANCER
    
    W.E. Farrell et al., "Methylation mechanisms in pituitary tumorigenesis", ENDOCR-R CA, 6(4), 1999, pp. 437-447
12. Hibberts, NA; Simpson, DJ; Bicknell, JE; Broome, JC; Hoban, R; Clayton, RN; Farrell, WE
    Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors
    CLINICAL CANCER RESEARCH
    
    N.A. Hibberts et al., "Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors", CLIN CANC R, 5(8), 1999, pp. 2133-2139
13. Simpson, DJ; Bicknell, JE; McNicol, AM; Clayton, RN; Farrell, WE
    Hypermethylation of the p16/CDKN2A/MTS1 gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas
    GENES CHROMOSOMES & CANCER
    
    D.J. Simpson et al., "Hypermethylation of the p16/CDKN2A/MTS1 gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas", GENE CHROM, 24(4), 1999, pp. 328-336
14. Frost, SJ; Simpson, DJ; Clayton, RN; Farrell, WE
    Transfection of an inducible p16/CDKN2A construct mediates reversible growth inhibition and G(1) arrest in the AtT20 pituitary tumor cell line
    MOLECULAR ENDOCRINOLOGY
    
    S.J. Frost et al., "Transfection of an inducible p16/CDKN2A construct mediates reversible growth inhibition and G(1) arrest in the AtT20 pituitary tumor cell line", MOL ENDOCR, 13(11), 1999, pp. 1801-1810
15. Anwar, S; White, J; Hall, C; Farrell, WE; Deakin, M; Elder, JB
    Sporadic colorectal polyps: Management options and guidelines
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    
    S. Anwar et al., "Sporadic colorectal polyps: Management options and guidelines", SC J GASTR, 34(1), 1999, pp. 4-11
16. Simpson, DJ; Magnay, J; Bicknell, JE; Barkan, AL; McNicol, AM; Clayton, RN; Farrell, WE
    Chromosome 13q deletion mapping in pituitary tumors: Infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas
    CANCER RESEARCH
    
    D.J. Simpson et al., "Chromosome 13q deletion mapping in pituitary tumors: Infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas", CANCER RES, 59(7), 1999, pp. 1562-1566
17. Farrell, WE; Simpson, DJ; Bicknell, J; Magnay, JL; Kyrodimou, E; Thakker, RV; Clayton, RN
    Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours
    BRITISH JOURNAL OF CANCER
    
    W.E. Farrell et al., "Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours", BR J CANC, 80(1-2), 1999, pp. 44-50
18. FARRELL WE; CLAYTON RN
    MOLECULAR-GENETICS OF PITUITARY-TUMORS
    Trends in endocrinology and metabolism
    
    W.E. Farrell e R.N. Clayton, "MOLECULAR-GENETICS OF PITUITARY-TUMORS", Trends in endocrinology and metabolism, 9(1), 1998, pp. 20-26
19. WORRALL SF; CORRIGAN M; HIGH A; STARR D; MATTHIAS C; WOLF CR; JONES PW; HAND P; GILFORD J; FARRELL WE; HOBAN P; FRYER AA; STRANGE RC
    SUSCEPTIBILITY AND OUTCOME IN ORAL-CANCER - PRELIMINARY DATA SHOWING AN ASSOCIATION WITH POLYMORPHISM IN CYTOCHROME-P450 CYP2D6
    Pharmacogenetics
    
    S.F. Worrall et al., "SUSCEPTIBILITY AND OUTCOME IN ORAL-CANCER - PRELIMINARY DATA SHOWING AN ASSOCIATION WITH POLYMORPHISM IN CYTOCHROME-P450 CYP2D6", Pharmacogenetics, 8(5), 1998, pp. 433-439
20. FARRELL WE; CLAYTON RN
    MOLECULAR-BIOLOGY OF HUMAN PITUITARY-ADENOMAS
    Annals of medicine
    
    W.E. Farrell e R.N. Clayton, "MOLECULAR-BIOLOGY OF HUMAN PITUITARY-ADENOMAS", Annals of medicine, 30(2), 1998, pp. 192-198
21. HUIZENGA NATM; DELANGE P; KOPER JW; CLAYTON RN; FARRELL WE; VANDERLELY AJ; BRINKMANN AO; DEJONG FH; LAMBERTS SWJ
    HUMAN ADRENOCORTICOTROPIN-SECRETING PITUITARY-ADENOMAS SHOW FREQUENT LOSS OF HETEROZYGOSITY AT THE GLUCOCORTICOID RECEPTOR GENE LOCUS
    The Journal of clinical endocrinology and metabolism
    
    N.A.T.M. Huizenga et al., "HUMAN ADRENOCORTICOTROPIN-SECRETING PITUITARY-ADENOMAS SHOW FREQUENT LOSS OF HETEROZYGOSITY AT THE GLUCOCORTICOID RECEPTOR GENE LOCUS", The Journal of clinical endocrinology and metabolism, 83(3), 1998, pp. 917-921
22. FARRELL WE; TALBOT JA; BICKNELL EJ; SIMPSON D; CLAYTON RN
    GENOMIC SEQUENCE-ANALYSIS OF A KEY RESIDUE (ARG(183)) IN HUMAN G-ALPHA(Q) IN INVASIVE NONFUNCTIONAL PITUITARY-ADENOMAS
    Clinical endocrinology
    
    W.E. Farrell et al., "GENOMIC SEQUENCE-ANALYSIS OF A KEY RESIDUE (ARG(183)) IN HUMAN G-ALPHA(Q) IN INVASIVE NONFUNCTIONAL PITUITARY-ADENOMAS", Clinical endocrinology, 47(2), 1997, pp. 241-244
23. BATES AS; FARRELL WE; BICKNELL EJ; MCNICOL AM; TALBOT AJ; BROOME JC; PERRETT CW; THAKKER RV; CLAYTON RN
    ALLELIC DELETION IN PITUITARY-ADENOMAS REFLECTS AGGRESSIVE BIOLOGICAL-ACTIVITY AND HAS POTENTIAL VALUE AS A PROGNOSTIC MARKER
    The Journal of clinical endocrinology and metabolism
    
    A.S. Bates et al., "ALLELIC DELETION IN PITUITARY-ADENOMAS REFLECTS AGGRESSIVE BIOLOGICAL-ACTIVITY AND HAS POTENTIAL VALUE AS A PROGNOSTIC MARKER", The Journal of clinical endocrinology and metabolism, 82(3), 1997, pp. 818-824
24. FARRELL WE; SIMPSON DJ; BICKNELL JE; TALBOT AJ; BATES AS; CLAYTON RN
    CHROMOSOME 9P DELETIONS IN INVASIVE AND NONINVASIVE NONFUNCTIONAL PITUITARY-ADENOMAS - THE DELETED REGION INVOLVES MARKERS OUTSIDE OF THE MTS1 AND MTS2 GENES
    Cancer research
    
    W.E. Farrell et al., "CHROMOSOME 9P DELETIONS IN INVASIVE AND NONINVASIVE NONFUNCTIONAL PITUITARY-ADENOMAS - THE DELETED REGION INVOLVES MARKERS OUTSIDE OF THE MTS1 AND MTS2 GENES", Cancer research, 57(13), 1997, pp. 2703-2709
25. SARHANIS P; REDMAN C; PERRETT C; BRANNIGAN K; CLAYTON RN; HAND P; MUSGROVE C; SUAREZ V; JONES P; FRYER AA; FARRELL WE; STRANGE RC
    EPITHELIAL OVARIAN-CANCER - INFLUENCE OF POLYMORPHISM AT THE GLUTATHIONE-S-TRANSFERASE GSTM1 AND GSTT1 LOCI ON P53 EXPRESSION
    British Journal of Cancer
    
    P. Sarhanis et al., "EPITHELIAL OVARIAN-CANCER - INFLUENCE OF POLYMORPHISM AT THE GLUTATHIONE-S-TRANSFERASE GSTM1 AND GSTT1 LOCI ON P53 EXPRESSION", British Journal of Cancer, 74(11), 1996, pp. 1757-1761
26. DOWNHAM MR; FARRELL WE; JENKINS HA
    ENDOPLASMIC-RETICULUM PROTEIN EXPRESSION IN RECOMBINANT NS0 MYELOMAS GROWN IN BATCH CULTURE
    Biotechnology and bioengineering
    
    M.R. Downham et al., "ENDOPLASMIC-RETICULUM PROTEIN EXPRESSION IN RECOMBINANT NS0 MYELOMAS GROWN IN BATCH CULTURE", Biotechnology and bioengineering, 51(6), 1996, pp. 691-696
27. PEARCE A; FARRELL WE; JENKINS HA
    CHARACTERIZATION OF THE ISOFORMS OF GRP78 USING 2-DIMENSIONAL ELECTROPHORESIS
    Biochemical Society transactions
    
    A. Pearce et al., "CHARACTERIZATION OF THE ISOFORMS OF GRP78 USING 2-DIMENSIONAL ELECTROPHORESIS", Biochemical Society transactions, 23(1), 1995, pp. 79-79